πŸ‡ΊπŸ‡Έ FDA
Patent

US 7935796

Monoclonal antibodies against ANGPTL3

granted A61KA61K2039/505A61P

Quick answer

US patent 7935796 (Monoclonal antibodies against ANGPTL3) held by LEXICON PHARMACEUTICALS, INC. expires Mon Apr 28 2031 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
LEXICON PHARMACEUTICALS, INC.
Grant date
Tue May 03 2011 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 28 2031 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
19
CPC classes
A61K, A61K2039/505, A61P, A61P3/00, A61P3/04